Warfarin Sodium Tablets recall: CGMP Deviations
Warfarin Sodium Tablets, USP, 2.5 mg, 100 Tablets per bottle, Rx only, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1714-01
Why was Warfarin Sodium Tablets recalled?
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Batch 2169041
- Product
- Warfarin Sodium Tablets, USP, 2.5 mg, 100 Tablets per bottle, Rx only, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1714-01
- Recalling firm
- CARDINAL HEALTHCARE
- Quantity
- 1 unit
- Distribution
- Nationwide USA
- Recall date
- January 3, 2024
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)